Finance

Lists
Why is AKBA down 2,44%?
Dive Deeper
AKBA:NASDAQ
Akebia Therapeutics Inc
0,85 USD
-2,44%
(-0,021) 1D
8-окт., 09:30:26 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AKBA...
Open
0,85 USD
High
0,86 USD
Low
0,85 USD
Mkt. cap
235,72 млн
Avg. vol.
7,76 млн
Volume
697,00
52-wk high
3,20 USD
52-wk low
0,81 USD
EPS
-0,11 USD
Beta
0,18
Shares outstanding
277,11 млн
No. of employees
194
Open
0,85 USD
High
0,86 USD
Low
0,85 USD
Mkt. cap
235,72 млн
Avg. vol.
7,76 млн
Volume
697,00
52-wk high
3,20 USD
52-wk low
0,81 USD
EPS
-0,11 USD
Beta
0,18
Shares outstanding
277,11 млн
No. of employees
194
News stories
From web sources and news partners
About Akebia Therapeutics Inc
CEO-
Employees194
Founded2007-ж., 1-янв.
HeadquartersКембридж, Массачусетс, Америка Кошмо Штаттары
Sector-
Websiteakebia.com
Analyst ratings
Based on 5 analysts giving stock ratings to AKBA in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for AKBA in the last 3 months.
Highest
Current 0,85 USD
6,00 USD (+604,14%)
Average
3,90 USD (+357,69%)
Lowest
1,00 USD (+17,36%)
Analyst
Recommendation
Action
Price target
Projected
Date
Julian Harrison
BTIG
Buy
Maintained
4,00 USD
+369,4%
09/14/2026
Ed Arce
Westpark Capital
Buy
Initiated
4,50 USD
+428,1%
09/08/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
4,00 USD
+369,4%
08/17/2026
Roanna Ruiz
Leerink Partners
Hold
Downgraded
1,00 USD
+17,4%
08/07/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
6,00 USD
+604,1%
08/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
58,77 млн
57,62 млн
53,54 млн
49,13 млн
Cost of goods sold
10,28 млн
10,93 млн
9,78 млн
9,58 млн
Cost of revenue
10,28 млн
10,93 млн
9,78 млн
9,58 млн
Research and development expenses
14,94 млн
26,65 млн
14,81 млн
14,06 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29,09 млн
26,09 млн
30,44 млн
28,17 млн
Operating expense
44,04 млн
52,74 млн
45,24 млн
42,23 млн
Total operating expenses
54,32 млн
63,67 млн
55,02 млн
51,81 млн
Operating income
4,45 млн
-6,05 млн
-1,48 млн
-2,68 млн
Other non operating income
1,45 млн
2,14 млн
459,00 миң
559,00 миң
EBT including unusual items
1,16 млн
-11,24 млн
-8,93 млн
-8,84 млн
EBT excluding unusual items
1,16 млн
-8,73 млн
-5,71 млн
-5,19 млн
Income tax expense
615,00 миң
1,01 млн
126,00 миң
70,00 миң
Effective tax rate
53,25%
-8,98%
-1,41%
-0,79%
Other operating expenses
-
-
-
-
Net income
540,00 миң
-12,24 млн
-9,05 млн
-8,91 млн
Net profit margin
0,92%
-21,25%
-16,91%
-18,13%
Earnings per share
-
-0,05
-0,03
-0,03
Interest and investment income
-
-
-
-
Interest expense
-4,75 млн
-4,83 млн
-4,69 млн
-3,07 млн
Net interest expenses
-4,75 млн
-4,83 млн
-4,69 млн
-3,07 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
4,77 млн
-5,73 млн
-1,15 млн
-2,10 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору